PHARMACOKINETICS OF INTRAPLEURAL VERSUS INTRAVENOUS ETOPOSIDE (VP-16) AND TENIPOSIDE (VM-26) IN PATIENTS WITH MALIGNANT PLEURAL EFFUSION

被引：0
|
作者：
MONTALDO, PG
FIGOLI, F
ZANETTE, ML
SORIO, R
ZUCCHETTI, M
TIRELLI, U
DINCALCI, M
机构：
[1] MARIO NEGRI INST PHARMACOL RES,VIA ERITREA 62,I-20157 MILAN,ITALY
[2] CTR RIFERIMENTO ONCOL,AVIANO,ITALY
来源：
ONCOLOGY | 1990年 / 47卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：55 / 61
页数：7
相关论文
共 50 条
  • [41] PHARMACOKINETICS AND TOXICITY OF THE EPIPODOPHYLLOTOXIN DERIVATIVE ETOPOSIDE (VP 16-213) IN PATIENTS WITH GESTATIONAL CHORIOCARCINOMA AND MALIGNANT TERATOMA
    BRINDLEY, CJ
    ANTONIW, P
    NEWLANDS, ES
    BAGSHAWE, KD
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 15 (01) : 66 - 71
  • [42] Ifosfamide (IFO), carboplatin (CBDCA) and etoposide (VP-16) combined with aquatherm induced 41.8°C whole body hyperthermia (WBH) for adult patients with malignant pleural mesothelioma.
    Bakhshandeh, A
    Bruns, I
    Eberhardt, K
    Demedts, A
    Kaukel, E
    Gatzemeier, U
    Dahlhoff, K
    Jäger, E
    Jäger, D
    Knuth, A
    Hegewisch-Becker, S
    Hossfeld, DK
    Wiedemann, GJ
    ANNALS OF ONCOLOGY, 2000, 11 : 113 - 113
  • [43] EFFECTS OF DIFFERENT EXTRACELLULAR PROTEIN CONCENTRATIONS (CONC) ON THE INVITRO UPTAKE AND CYTOTOXICITY OF ANTITUMOR DRUGS THAT ARE EXTENSIVELY PROTEIN-BOUND (PB) - ETOPOSIDE (VP16) AND TENIPOSIDE (VM26)
    SINKULE, JA
    CHOI, KE
    SOHN, CH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 383 - 383
  • [44] PHASE-II STUDY OF VM-26 AND VP-16 IN RECURRENT PRIMARY BRAIN-TUMOR - A COLLABORATIVE TRIAL OF NORTH CENTRAL CANCER-TREATMENT GROUP AND MAYO-CLINIC
    CASCINO, T
    DINAPOLI, R
    KROOK, J
    OFALLON, J
    EVERSON, L
    MARSCHKE, R
    CULLINAN, S
    NEUROLOGY, 1986, 36 (04) : 336 - 336
  • [45] EPIPODOPHYL LOTOXINS VP-16-213 AND VM-26 - A PHASE-I STUDY OF 5-DAY CONTINUOUS INTRAVENOUS-INFUSION (CI) IN BRONCHOGENIC CARCINOMAS
    BOOSER, DJ
    SPITZER, G
    CHIUTEN, DF
    VALDIVIESO, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 508 - 508
  • [46] TOPOISOMERASE-II-MEDIATED LESIONS IN NASCENT DNA - COMPARISON OF THE EFFECTS OF EPIPODOPHYLLOTOXIN DERIVATIVES, VM-26 AND VP-16, AND 9-ANILINOACRIDINE DERIVATIVES, META-AMSA AND ORTHO-AMSA
    WOYNAROWSKI, JM
    SIGMUND, RD
    BEERMAN, TA
    BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 950 (01) : 21 - 29
  • [47] Mobilisation of blood progenitor cells with ifosfamide and etoposide (VP-16) in combination with recombinant human G-CSF (filgrastim) in patients with malignant lymphomas or solid tumours
    Baars, JW
    Holtkamp, MJ
    Nooyen, WJ
    Walll, EVD
    Velde, AT
    Dalesio, O
    SlaperCortenbach, ICM
    Schoot, EVD
    Richel, DJ
    Gerritsen, WR
    Schornagel, JH
    Rodenhuis, S
    ANTICANCER RESEARCH, 1996, 16 (5B) : 3089 - 3095
  • [48] A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non-small-cell lung cancer
    Nie, Keke
    Zhang, Zhen
    You, Yunhong
    Zhuang, Xingjun
    Zhang, Chunling
    Ji, Youxin
    THORACIC CANCER, 2020, 11 (01) : 8 - 14
  • [49] TOTAL-BODY IRRADIATION (TBI), ETOPOSIDE (VP-16) AND CYCLOPHOSPHAMIDE (CY) WITH AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) FOR PATIENTS WITH MALIGNANT-LYMPHOMA (ML)
    WEAVER, CH
    PETERSEN, FB
    BENSINGER, W
    APPELBAUM, FA
    BUCKNER, CD
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1130 - 1130
  • [50] Chinese herbal injections versus intrapleural cisplatin for lung cancer patients with malignant pleural effusion: A Bayesian network meta-analysis of randomized controlled trials
    Xu, Yi-Fang
    Chen, Yun-Ru
    Bu, Fan-Long
    Huang, Yu-Bei
    Sun, Yu-Xin
    Li, Cheng-Yin
    Sellick, Jodi
    Liu, Jian-Ping
    Qin, Dan-Mei
    Liu, Zhao-Lan
    FRONTIERS IN ONCOLOGY, 2022, 12
12345